Ketamine use in critically ill patients: a narrative review.
Thais Dias MidegaRenato Carneiro de Freitas ChavesCarolina AshiharaRoger Monteiro AlencarVerônica Neves Fialho QueirozGiovana Roberta ZelezogloLuiz Carlos da Silva VilanovaGuilherme Benfatti OlivatoRicardo Luiz CordioliBruno de Arruda BravimThiago Domingos CorreaPublished in: Revista Brasileira de terapia intensiva (2022)
Ketamine is unique among anesthetics and analgesics. The drug is a rapid-acting general anesthetic that produces an anesthetic state characterized by profound analgesia, preserved pharyngeal-laryngeal reflexes, normal or slightly enhanced skeletal muscle tone, cardiovascular and respiratory stimulation, and occasionally a transient and minimal respiratory depression. Research has demonstrated the efficacy of its use on anesthesia, pain, palliative care, and intensive care. Recently, it has been used for postoperative and chronic pain, as an adjunct in psychotherapy, as a treatment for depression and posttraumatic stress disorder, as a procedural sedative, and as a treatment for respiratory and/or neurologic clinical conditions. Despite being a safe and widely used drug, many physicians, such as intensivists and those practicing in emergency care, are not aware of the current clinical applications of ketamine. The objective of this narrative literature review is to present the theoretical and practical aspects of clinical applications of ketamine in intensive care unit and emergency department settings.
Keyphrases
- pain management
- chronic pain
- emergency department
- palliative care
- posttraumatic stress disorder
- intensive care unit
- skeletal muscle
- healthcare
- depressive symptoms
- public health
- patients undergoing
- advanced cancer
- postoperative pain
- adverse drug
- intellectual disability
- adipose tissue
- quality improvement
- mechanical ventilation
- physical activity
- blood brain barrier
- brain injury
- replacement therapy
- quantum dots